[1]王 敏,徐 建,安 睿,等.经肱动脉行肝动脉灌注化疗患者围术期护理干预方案的构建及应用研究[J].介入放射学杂志,2025,34(10):1129-1133.[doi:10.3969/j.issn.1008-794X.2025.10.017]
　WANG Min,XU Jian,AN Rui,et al.Perioperative nursing intervention scheme for patients undergoing hepatic arterial infusion chemotherapy via brachial artery access:its construction and clinical application[J].J Intervent Med,2025,34(10):1129-1133.[doi:10.3969/j.issn.1008-794X.2025.10.017]
点击复制

经肱动脉行肝动脉灌注化疗患者围术期护理干预方案的构建及应用研究()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
34
期数:
2025年10
页码:
1129-1133
栏目:
护理论坛
出版日期:
2025-10-25

文章信息/Info

Title:
Perioperative nursing intervention scheme for patients undergoing hepatic arterial infusion chemotherapy via brachial artery access:its construction and clinical application
文章编号:
1008-794X(2025)-010-1129-05
作者:
王 敏;  徐 建;  安 睿;  赵 珅;  高 平;  闫 静
710032 陕西西安 空军军医大学第一附属医院介入手术中心
Author(s):
WANG Min; XU Jian; AN Rui; ZHAO Shen; GAO Ping; YAN Jing.
Interventional Surgery Center,First Affiliated Hospital of Air Force Military Medical University,Xi'an,Shaanxi Province 710032,China
关键词:
肝动脉灌注化疗;  恶性肝肿瘤;  肱动脉;  护理干预;  围术期护理
DOI:
10.3969/j.issn.1008-794X.2025.10.017
文献标志码:
A
摘要:
目的 构建经肱动脉行肝动脉灌注化疗(HAIC)患者围术期的护理干预方案,并探讨其应用效果。方法 通过系统文献检索法构建护理干预方案,选取2022年2月至2023年8月空军军医大学第一附属医院90例确诊肝恶性肿瘤行HAIC治疗患者,进行临床验证并评估其应用效果。结果 通过2轮专家函询,最终形成了包含5个一级指标和16个二级指标的护理干预方案。在临床验证中,试验组实施护理干预方案后,静脉炎和肢体肿胀发生率分别从17.78%降至2.22%和33.33%降至8.89%; 焦虑和抑郁情绪显著改善,HADS评分分别下降35.2%和36.6%; EORTC QLQ-C30评分在躯体、角色、情绪和社会功能等维度显著提高,生活质量显著改善(P<0.05)。此外,干预组患者在癌症症状困扰方面(如疼痛、恶心等)显著减少,症状严重度和困扰程度明显降低,表明护理干预对缓解患者的症状困扰发挥了重要作用。结论 经肱动脉HAIC患者围术期的护理干预方案科学实用,为肝恶性肿瘤患者的治疗护理提供了重要参考依据。

参考文献/References:

[1] Xia C,Dong X,Li H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J(Engl),2022,135:584-590.
[2]饶圣祥,张 岚.《原发性肝癌诊疗指南(2024年版)》影像诊断更新解读——聚焦亚厘米肝癌的诊断[J].中国医学影像学杂志,2024,32:529-532.
[3]Nagai H,Kanayama M,Higami K,et al.Twenty-four hour intra-arterial infusion of 5-fluorouracil,cisplatin,and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma[J].World J Gastroenterol,2007,13:280-284.
[4]He MK,Le Y,Li QJ,et al.Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma:a prospective non-randomized study[J].Chin J Cancer,2017,36:83.
[5]陈敏山,潘扬勋.血管介入治疗在肝癌转化治疗领域的研究进展[J].中华消化外科杂志,2022,21:210-216.
[6]王鹏程,廖 晖,徐小平.基于FOLFOX方案的肝动脉灌注化疗在肝癌围手术期的应用进展[J].肝胆胰外科杂志,2024,36:110-115.
[7]黄子寅,凯比努尔·艾尔肯,培尔顿·米吉提.EORTC QLQ-C30汇总评分对中国结直肠癌患者预后预测价值[J].中华肿瘤防治杂志,2024,31:625-631.
[8]Portenoy RK,Thaler HT,Kornblith AB,et al.The Memorial Symptom Assessment Scale:an instrument for the evaluation of symptom prevalence,characteristics and distress[J].Eur J Cancer,1994,30:1326-1336.
[9]Graf J,Stengel A.Psychological burden and psycho-oncological interventions for patients with hepatobiliary cancers:a systematic review[J].Front Psychol,2021,12:662777.
[10]蒋 维,罗 玲,张运芝,等.基于心理复原模型的动机性访谈对原发性肝癌患者创伤后成长的影响[J].护理学报,2022,29:19-24.
[11]李春艳.分析多学科联合协作在肝癌手术患者延续性护理中的应用[J].中国医药指南,2023,21:166-168.
[12]Ma Y,He B,Jiang M,et al.Prevalence and risk factors of cancer-related fatigue:a systematic review and meta-analysis[J].Int J Nurs Stud,2020,111:103707.
[13]黄长娟.实施个性化护理对放化疗高血压肺癌患者生活质量的影响分析[J].心血管病防治知识,2023,13:38-40.
[14]倪 翔,张志勇,谭 伟,等.Snyder希望理论模型护理对慢性心力衰竭患者自我感受负担、情绪状态的影响[J].国际精神病学杂志,2024,51:649-652,672.
[15]2025年《中华护理杂志》专题策划[J].中华护理杂志,2025,60:68.
[16]陈 敏,聂臣聪,邹雪娜.某三甲医院住院患者静脉治疗横断面调查分析[J].世界最新医学信息文摘(连续型电子期刊),2019,19:251-252.
[17]王 洁,李含英,吕展杨,等.肝动脉灌注化疗的围手术期护理[J].介入放射学杂志,2024,33:431-437.
[18]殷梦杰,付守忠,戴 锋,等.肝动脉灌注化疗联合卡瑞利珠单抗及索拉非尼治疗中晚期肝癌的疗效与安全性分析[J].介入放射学杂志,2024,33:1212-1217.
(收稿日期:2024-12-30)
(本文编辑:茹 实)

相似文献/References:

[1]李晓光,金征宇,潘杰,等.肝动脉化疗或栓塞治疗胰腺神经内分泌肿瘤肝转移的疗效分析[J].介入放射学杂志,2010,(06):442.
　LI Xiaoguang,JIN Zhengyu,PAN Jie,et al.Hepatic transarterial chemoperfusion and chemoembolization for the treatment of liver metastases from pancreatic neuroendocrine tumors：a therapeutic analysis[J].J Intervent Med,2010,(10):442.
[2]陈伟敏,罗佐权.肝癌肝动脉灌注化疗与静脉输注硫代硫酸钠的“双路”疗法18例报告[J].介入放射学杂志,1992,(01):26.
[3]牛树茂,徐元贞,赵殿有,等.肝动脉灌注化疗后引起带状疱疹样皮疹六例报告[J].介入放射学杂志,1994,(01):54.
[4]秦伟,巫北海.5-FUDR经肝动脉灌注致硬化性胆管炎[J].介入放射学杂志,1996,(01):59.
[5]杨文娟,吴美儿,张克勤,等.肝动脉灌注化疗对Ⅱ-Ⅲ期肝癌早期疗效的预测价值[J].介入放射学杂志,2025,34(05):493.[doi:10.3969/j.issn.1008-794X.2025.05.009]
　YANG Wenjuan,WU Meier,ZHANG Keqin,et al.The prediction value of the early efficacy of hepatic arterial infusion chemotherapy in patients with stage Ⅱ-Ⅲ hepatocellular carcinoma[J].J Intervent Med,2025,34(10):493.[doi:10.3969/j.issn.1008-794X.2025.05.009]
[6]中国抗癌协会肿瘤介入学专业委员会,中国抗癌协会肿瘤介入学专业委员会化疗与免疫治疗分委会.改良式经皮肝动脉化疗药盒植入技术中国专家共识（2022版）[J].介入放射学杂志,2022,31(07):633.
　Professional Committee of Oncology Intervention,China Anti-Cancer Association,Chinese expert consensus on the modified implantation technique of port-catheter system for percutaneous hepatic arterial infusion chemotherapy（version 2022）[J].J Intervent Med,2022,31(10):633.
[7]徐永康,付舒敏,李　丹,等.肝动脉灌注化疗联合系统治疗在原发性肝癌中的研究进展[J].介入放射学杂志,2023,32(01):94.
　XU Yongkang,FU Shumin,LI Dan,et al.Research progress in hepatic arterial infusion chemotherapy combined with systemic therapy for the treatment of primary hepatocellular carcinoma[J].J Intervent Med,2023,32(10):94.
[8]曹佳伟,李慧婷,徐玲玲,等.晚期肝癌患者行HAIC术后股动脉并发假性动脉瘤致骨筋膜室综合征的护理1例[J].介入放射学杂志,2024,33(04):459.
　CAO Jiawei,LI Huiting,XU Lingling,et al.Nursing care for osteofascial compartment syndrome caused by iatrogenic pseudoaneurysm in one patient with advanced liver cancer after receiving hepatic artery infusion chemotherapy[J].J Intervent Med,2024,33(10):459.
[9]张岩基,王汇源,李浩,等.经导管动脉化疗栓塞和肝动脉灌注化疗治疗肝细胞癌现状和进展[J].介入放射学杂志,2024,33(09):1039.
　ZHANG Yanji,WANG Huiyuan,LI Hao,et al.Current status and progress of TACE and HAIC in the treatment of hepatocellular carcinoma[J].J Intervent Med,2024,33(10):1039.
[10]殷梦杰,付守忠,戴锋,等.肝动脉灌注化疗联合卡瑞利珠单抗及索拉非尼治疗中晚期肝癌的疗效与安全性分析 [J].介入放射学杂志,2024,33(11):1212.
　YIN Mengjie,FU Shouzhong,DAI Feng,et al.Hepatic arterial infusion chemotherapy combined with carrelizumab and sorafenib for the treatment of advanced hepatocellular carcinoma：its clinical efficacy and safety[J].J Intervent Med,2024,33(10):1212.

备注/Memo

备注/Memo:
通信作者: 闫 静 E-mail:315078324@qq.com
更新日期/Last Update: 2025-10-25